What other stocks do shareholders of Alterity Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alterity Therapeutics investors own include Novavax (NVAX) , Catalyst Pharmaceuticals (CPRX) , Intercept Pharmaceuticals (ICPT) , Rigel Pharmaceuticals (RIGL) , Arena Pharmaceuticals (ARNA) , Conatus Pharmaceuticals (CNAT) , Gilead Sciences (GILD) , GW Pharmaceuticals (GWPH) , Inovio Pharmaceuticals (INO) and Microbot Medical (MBOT) .

NASDAQ:PRAN

Alterity Therapeutics (PRAN) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free PRAN Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $1.97
▼
$2.16
50-Day Range: $0.95
▼
$2.06
52-Week Range: $1.09
▼
$2.91

Volume: 25,391 shs
Average Volume: 130,956 shs
Market Capitalization: $19.05 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Competitors Social Media

Get Alterity Therapeutics alerts:

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Alterity Therapeutics Stock (NASDAQ:PRAN)

Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

PRAN Stock News Headlines

April 18, 2024 | finance.yahoo.com

Kazia Therapeutics Limited (KZIA)

December 21, 2023 | nasdaq.com

Alterity Therapeutics Says Phillip Hains To Replace Kathryn Andrews As CFO

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

December 21, 2023 | markets.businessinsider.com

Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer

December 4, 2023 | seekingalpha.com

Alterity jumps after promising data on Parkinson's candidate

December 4, 2023 | investorplace.com

Why Is Alterity Therapeutics (ATHE) Stock Up 150% Today?

October 31, 2023 | morningstar.com

Axsome Therapeutics Inc AXSM

October 8, 2023 | morningstar.com

ADRs End Higher; Orchard Therapeutics PLC Climbs 96%

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

August 23, 2023 | technews.tmcnet.com

Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson's and Alzheimer's

March 14, 2023 | technews.tmcnet.com

Alterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer's Disease

January 30, 2023 | marketwatch.com

Alterity: Study Shows ATH434 Prevents Loss of Brain Cells in Parkinson's Disease Animal Model

September 26, 2022 | benzinga.com

Alterity Therapeutics Stock (OTC:PRNAF), Analyst Ratings, Price Targets, Predictions

September 20, 2022 | msn.com

Here's Why Alterity Therapeutics Shares Are Volatile

See More Headlines

Receive PRAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:PRAN
CUSIP: N/A
CIK: 1131343
Web: www.pranabio.com
Phone: (139) 349-4906
Fax: N/A
Employees: 14
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.37
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $150,000.00
Price / Sales: 126.97
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.40 per share
Price / Book: 1.53

Miscellaneous

Outstanding Shares: 8,900,000
Free Float: N/A
Market Cap: $19.05 million
Optionable: Not Optionable
Beta: 1.05

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Geoffrey Paul Kempler
Executive Chairman & Chief Executive Officer
Kathryn J. E. Andrews
Chief Financial Officer
David A. Stamler
Chief Medical Officer & SVP-Clinical Development
Phillip Allen Hains
Secretary

Key Competitors

View All Competitors

PRAN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Alterity Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Alterity Therapeutics investors own include Novavax (NVAX), Catalyst Pharmaceuticals (CPRX), Intercept Pharmaceuticals (ICPT), Rigel Pharmaceuticals (RIGL), Arena Pharmaceuticals (ARNA), Conatus Pharmaceuticals (CNAT), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH), Inovio Pharmaceuticals (INO) and Microbot Medical (MBOT).

This page (NASDAQ:PRAN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Alterity Therapeutics (PRAN) Stock Price, News & Analysis

About Alterity Therapeutics Stock (NASDAQ:PRAN)

PRAN Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

PRAN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info